Zoledronic Acid (Zometa) for the Management of Tumor-Induced Hypercalcemia (TIH) and Malignant Bone Pain (MBP) in the Community: A Feasibility Study
Latest Information Update: 19 Jul 2022
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Cancer pain; Malignant hypercalcaemia; Musculoskeletal pain
- Focus Therapeutic Use